Since the establishment of Glomeria, we dedicate all resources to research and development of innovative products that can make a real benefit to patients undergoing long-term therapy. Through our commitment, patients with...
Our most advanced program concerns the peritoneal dialysis in patients with chronic renal failure. We have achieved a real therapeutic platform in order not only to integrate the pharmacological approach with the biomedical one,...
Our goal is to offer a wide and valuable therapeutic option in the treatment of severe cardiovascular disease, particularly heart failure refractory to diuretics associated with a significant decrease in kidney function, a condition known as cardiorenal syndrome.
The researches by Glomeria Therapeutics have been carried out in collaboration with leading Italian and foreign research centers and have been published in international peer reviewed journals.
Glomeria Therapeutics is creating comprehensive therapeutic platforms for the treatment of kidney and cardiovascular disease.
The therapeutic platform for peritoneal dialysis has reached the level of the most advanced technological innovation.
For more information, login and download the comprehensive brochures of Glomeria Therapeutics.